It is often inactivated in cancer cells due to mutations leading to a “loss of function” (e.g., in its DNA-binding capabilities) or p53 is delocalized into the cytoplasm due to NES unmasking and active export [9,10] reviewed in [11,12]. The gene discussed is TP53; the disease is cancer.